ENTRY       D11904                      Drug
NAME        Zansecimab (USAN)
FORMULA     C6438H9888N1704O2034S48
EXACT_MASS  145150.9278
MOL_WEIGHT  145240.7137
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYSFT DYNMVWVRQA PGQGLEWMGY IDPYNGGTGY
            NQKFEGRVTM TTDTSTSTAY MELRSLRSDD TAVYYCARTR DRYDVWYFDV WGQGTLVTVS
            SASTKGPSVF PLAPCSRSTS ESTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSSLGTK TYTCNVDHKP SNTKVDKRVE SKYGPPCPPC PAPEAAGGPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSQE DPEVQFNWYV DGVEVHNAKT KPREEQFNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKGLP SSIEKTISKA KGQPREPQVY TLPPSQEEMT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSR LTVDKSRWQE
            GNVFSCSVMH EALHNHYTQK SLSLSLG
            (Light chain)
            DIQMTQSPSS VSASVGDRVT ITCKASQDVY IAVAWYQQKP GKAPKLLIYW ASTRDTGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCHQ YSSYPPTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H135-L214, H148-H204, H227-H'227, H230-H'230, H262-H322, H368-H426, H'22-H'96, H'135-L'214, H'148-H'204, H'262-H'322, H'368-H'426, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Anti-angiopoietin 2 antibody
  TYPE      Monoclonal antibody
COMMENT     Enhancing endothelial stabilization and prevention of acute respiratory distress syndrome (ARDS) in patients with COVID-19
TARGET      ANGPT2 [HSA:285] [KO:K05466]
  PATHWAY   hsa04010(285)  MAPK signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Growth factors (RTK-binding)
                ANGPT2
                 D11904  Zansecimab (USAN)
DBLINKS     CAS: 2415205-37-5
///
